|Treatment Naive with Resistance
Nov 23, 2013
Hi Doc, I'm trying to help a friend with low-English skills navigate being newly poz. He's very confused by the medical jargon, but doesn't want me to come to the doctor with him for cultural reasons (doctor is from his country and might perceive me being there as affirmation of my friends homosexuality). Thus, I'm trying to help him make sense of some of this second-hand.
His doctor told him that he cannot take Stribild because he is resistant to Edurant or ripilivine. Can you help us understand why that is? I thought that the main compound in Edurant was not in Stribild.
Also, how common is Edurant resistance in treatment naive people. I've not heard of it before. Particularly for someone who contracted in a part of the world where that drug is less common.
Response from Dr. Young
Hello B and thanks for posting.
If one assumes that your friend indeed has transmitted NNRTI resistance (to rilpivirine/Edurant), then I think that your question may be simply related to a misunderstanding. Rilpivirine is found not in the single tablet regimen of Stribild, but rather the single tablet regimen called Complera (or Eviplera in Europe).
Transmitted resistance to NNRTIs is quite common, but isolated resistance to rilpivirine is less so. To fully answer your question, it would be helpful to know the mutation pattern that the virus isolated from your friend has.
I hope this is helpful, and please feel free to write back. BY
hiv/aids and copd
PEP, 2 or better 3 drugs?
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.